Funded Tech Companies

Aktis Oncology

Aktis Oncology is a biopharmaceutical tech venture, located in Princeton. Financial backing was provided by Bristol-Myers Squibb, Novartis Venture Fund and Octagon Investments Fund.

Company Overview

Company Name
Aktis Oncology
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
Undisclosed
Princeton, NJ 08540
USA
Phone
Undisclosed
Email Address

Company Background Information

Overview
Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers. Founded and incubated by MPM Capital, the company has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy.
Profile
Aktis Oncology LinkedIn Company Profile
Social Media
Aktis Oncology Company Twitter Account
Company News
Aktis Oncology News
Facebook
Aktis Oncology on Facebook
YouTube
Aktis Oncology on YouTube
Last Transaction
3/19/2021

Financing History

Date
Type
Amount
Venture Equity
$72,000,000


Management Team

Title
Name
Email & Social
Chairman
Todd Foley
  Todd Foley LinkedIn Profile  Todd Foley Twitter Account  Todd Foley News  Todd Foley on Facebook
Chief Executive Officer
Matthew Roden
  Matthew Roden LinkedIn Profile  Matthew Roden Twitter Account  Matthew Roden News  Matthew Roden on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Aktino | Aktivate

 

Share this article

 


About Our Venture Capital Database

Our data comes from VentureDeal.com, a market leader in private equity transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary